Open Nav

Filtered by:

Clear All

Speakers

Alexis Ji Illumina Ventures Partner Jimmy Z. Zhang LAV (Lilly Asian Ventures) Venture Partner Jeffrey Abraham Akili Interactive VP of Access & Trade Eric Adams InMed Pharmaceuticals Inc. President & CEO Parvez Ahammad BlackThorn Therapeutics Head of Data Science Jiyoung Ahn HPBIO Inc. Senior executive Directer Mark Allen Elevian, Inc. CoFounder & CEO Simon Allen COHBAR CEO Sam Alworth AcuraStem Incorporated Chief Executive Officer John Amos VIVUS, Inc. Chief Executive Officer Armando Anido Zynerba Pharmaceuticals Chief Executive Officer William Annett OncoCyte Corporation President & CEO Yoram Ashery NOBIO LTD. CEO Ignacio Asial DotBio Pte. Ltd. CEO Vas Bailey ARTIS Ventures Partner Rahul Ballal Imara CEO Josep Bassaganya-Riera Landos Biopharma Chairman and CEO Alexey Bazarov Enlil Therapeutics CEO Noah Beerman Poxel SA EVP, Business Development and President US Operations Joshua Berlin Executive Director & Editor of New Ventures, BioCentury David Berry Flagship Pioneering General Partner Sudhir Bhatia Genekam Biotechnology AG CEO Tom Bliss Genisphere CEO Bob Blomquist Sinfonia Biotherapeutics, Inc. CEO Steven Braithwaite Alkahest Chief Scientific Officer Matt Brauer Third Rock Ventures Data Science Consultant Jeffrey Brewer Bigfoot Biomedical President & Chief Executive Officer Isaac Bright RubrYc Therapeutics, Inc. CEO Tom Burns XOMA Corporation CFO Michael Byrnes Alkahest, Inc. Chief Financial Officer Jim Caggiano Dendreon Pharmaceuticals LLC Chief Executive Officer Trent Carrier CytoSen CEO Ken Carson Flatiron Health Senior Medical Director Stephen Cary Handa Pharmaceuticals, Inc. Executive Vice President - Business Development Ruey-Kang Chang QT Medical CEO Rowan Chapman Johnson & Johnson Innovation, California Head, Johnson & Johnson Innovation, California Alice Chen Accelerator Life Science Partners Vice President Karina Chmielewski Third Rock Ventures Senior Director, Platform Operations Keting Chu Lyfe Capital Venture Partner J. Robert Coleman Codagenix, Inc. COO John Commissiong Trimeric Therapeutics, Inc. President & CSO Bill Crossman Phoenix PharmaLabs, Inc. CEO Jie D’Elia Bristol-Myers Squibb Executive Director, Business Development Transactions Karim Dabbagh Second Genome, Inc. CEO Rajeev Dadoo S.R. One Limited Partner Davide D'Amico ZeClinics CEO Gini Deshpande NuMedii, Inc. Founder & CEO of NuMedii Ira Deyhimy SELFA, Inc. CEO Douglas Doerfler MaxCyte, Inc. President & CEO Thomas W. Dubensky Jr. Tempest Therapeutics President & CEO of Tempest Therapeutics Glyn Edwards Summit Therapeutics Chief Executive Officer Jeremy Ellis Fry Laboratories, LLC Chief Scientific Officer Erik Emerson Mezzion Pharmaceuticals EVP Commercial Operations Tim Erickson IngenoVax Chief Scientist Cartier Esham Biotechnology Innovation Organization (BIO) Executive Vice President, Emerging Companies Brian Feth Xcell Biosciences CEO Simone Fishburn BioCentury Vice President and Executive Editor of BioCentury and BioCentury Innovations Pawel Fludzinski AmideBio CEO & President John Forrest VERAVAS CEO Gordon Foulkes FBM Therapeutics CEO Anna French Qiming Venture Partners USA Principal Jeff Galvin American Gene Technologies CEO Mary Gardner DelNova, Inc. CEO & Founder Paul Garofolo Locus Biosciences, Inc. Chief Executive Officer Amir Genosar Founder and CEO Pablo Gersberg BlackThorn Therapeutics Sr Director, Digital Solutions Matt Gevaert KIYATEC CEO Corey Goodman venBio Partners Managing Partner Sirj (Srijib) Goswami Insight RX, Inc. (UCSF) CEO Linda Grais Ocera Therapeutics Former President and Chief Executive Officer Kevin Grimes Stanford University Co-Director, SPARK Translational Research Program Ken Haas Abingworth Partner Thilo Hanemann Rhodium Group Director Shelley Hartman Aegle Therapeutics Corporation CEO Izhar Hasan RHNanopharmacuticals, LLC Chief Scientifc officer & Co founder Bill Hearl Immunomic Therapeutics, Inc. Founder and CEO Peter Heifetz OrPro Therapeutics Inc President and CEO Scott Hensley ivWatch, LLC VP, Sales & Business Development Terry Hermiston GLAdiator Biosciences, Inc CEO Timothy Herpin Caribou Biosciences Chief Business Officer Carole Ho Denali Therapeutics Chief Medical Officer, Head of Development J. Kenneth Hoober Susavion Biosciences, Inc. Chief Scientific Officer Ed Hurwitz, JD, MBA MPM Capital Managing Director Laura Indolfi PanTher Therapeutis, Inc. CEO Vipul Jain Advancells Founder & CEO Cameron Johnson Nucleus Network CEO Daniel Jones Aural Analytics, Inc. CEO Karin Jooss Gritstone Oncology Executive Vice President of Research and Chief Scientific Officer Jim Joyce Aethlon Medical, Inc. Founder, CEO Suh-Hang (Hank) Juo MyopiaCure founder/CSO/CEO David Kalergis Diffusion Pharmaceuticlas Inc. CEO and Chairman Matthew Kalnik Antidote Therapeutics, Inc. President & CEO Ilana Katsnelson New Horizons Pharma President Jayne Kauffman Infinity Pharmaceuticals Sr. Executive Coordinator Colin Kealey Monarch Biosciences Chief Medical Officer Thomas Kelleher Xylome Corporation CEO Eugene P. Kennedy NewLink Genetics Chief Medical Officer Michael Keyoung C-Bridge Capital Managing Director and Head of North America Nina Kjellson Canaan Partners General Partner David B. Klein Click Therapeutics, Inc. Co-founder & CEO David Klein Click Therapeutics, Inc. Executive Chairman, President & CEO John Kollins Satsuma Pharmaceuticals, Inc. Cofounder, President & CEO David Konerding insitro Senior Lead Data Engineer Scott Kozak Universal Sequencing Technology (UST) Chief Business Officer Thomas Krol Axolo Pharma Chief Development Officer Ramesh Kumar Onconova Therapeutics, Inc. CEO Paul Laikind ViaCyte President and Chief Executive Officer Paul Laikind ViaCyte, Inc. President and CEO Sanjay Lakhotia Zenith Epigenetics Ltd. Chief Business Officer Kenneth LaMontagne The Leukemia & Lymphoma Society Vice President, Research TAP (Therapy Acceleration Program) Jed Latkin Navidea BioPharmaceuticals Interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer Kenneth Lebioda Resverlogix Corp. Senior Vice President of Business and Corporate Development SJ Lee Orum Therapeutics Founder & Executive Officer Louis Lehot DLA Piper Partner, Co-Chair, US Emerging Growth and Venture Capital, Co-Managing Partner, Silicon Valley office Pedro Lichtinger ChemioCare Chairman and CEO Gracie Lieberman Genentech Director of Regulatory Policy Bob Linke Embera NeuroTherapeutics, Inc. President & CEO Yue Liu Ab Studio Inc. CEO Aaron Lu ImCare Biotech CEO Mary Ludlam Cairn Biosciences CEO Sanjeev Luther Rafael Pharmaceuticals President & CEO Sean MacLeod FenoLogica Biosciences CEO & Founder Scott Maguire Angèle Maki Merck & Co Executive Director of Business Development & Licensing Upendra Marathi 7 Hills Pharma Founder and CEO Stephanie Marrus University of California, San Francisco (UCSF) Director, Entrepreneurship Center Kelly Martin Biotechnology Innovation Organization (BIO) Vice President, Business Solutions Matt McAviney NEA Principal Vimal Mehta BioXcel Therapeutics CEO, Founder Thorsten Melcher Xyphos Biosciences, Inc. Chief Business Officer Elliot Menschik Amazon/Amazon Web Services Bradley Messmer Abreos Biosciences CEO Lydia Meyer-Turkson DiaCarta Inc Strategic Consultant to Diacarta Randy Milby Hillstream BioPharma Inc. CEO Paul Miller Synlogic Chief Scientific Officer KT Moortgat AbbVie Director, AbbVie Ventures Guillermo Morales SignalRx Pharmaceuticals, Inc. Chief Business Officer & Director of Research Alex Morgan Khosla Ventures Principal Johannes Mueller Berlin Cures President Craig Muir Third Rock Ventures Partner/Chief Technology Officer Susanne Mulligan BMO Managing Director Brian Murphy Nemus Bioscience, Inc. CEO - CMO Antoun Nabhan Pear Therapeutics Vice President of Corporate Development Gail Naughton Histogen CSO, CBDO & Founder Jon Newland Sindolor LLC Managing Partner/Co-Founder Martin Noel BendaRx Corp CEO Peter Noymer Kedalion Therapeutics, Inc. CEO Michael J. O'Donnell Morrison & Foerster Partner Frederic Ors IMV Inc. CEO Edward Painter A2A Pharmaceuticals CEO Deepa Pakianathan Delphi Ventures Managing Partner Rifat Pamukcu RxMP Therapeutics, Inc. Presidet & CEO Shyam Patel California Institute for Regenerative Medicine (CIRM) Associate Director for Portfolio Development and Review Snehal Patel Greenwich LifeSciences Vice President Julien Pham Genprex, Inc. President and Chief Operating Officer Martin Philips Opsidio CEO Richard Pither Cytox CEO Mark E. Plotkin Covington & Burling LLP Partner David Portman Sermonix Pharmaceuticals LLC Chief Executive Officer Rahul Puri OncoTAb, Inc. CEO Mohammed Qadir Fusion Genomics Corporoation CSO Venu Raman Natsar Pharmaceuticals Chief Scientific Officer Jeremy Rassen Aetion Co-Founder, President and Chief Science Officer Willie Reaves Biotechnology Innovation Organization (BIO) Director, Partnering Products & Services Gilly Regev SaNOtize Research and Development Corp CEO Dawson Reimer Cerebra Health Inc. President Sally Ann Reiss Ativo TX, dba Il-2rx Inc CEO Susan Rosenbaum Lauren Sciences LLC Founder, Chairman & CEO Jeff Ross Miromatrix Medical Inc. CEO Jennifer Rossi Flaskworks President & CEO Pieter Rottiers ActoBio Therapeutics CEO Charles S. Ryan Neurotrope CEO Robert Ryan Innova Therapeutics CEO Timothy Salmon Socium Therapeutics, Inc. Co-Founder, President & Chief Executive Officer Camille Samuels Venrock Partner Arthur Sands Nurix, Inc. CEO SATYEN SANGHAVI REGROW BIOSCIENCES PVT LTD CHIEF SCIENTIFIC OFFICER & CO-FOUNDER Daniela Santiesteban Salarius Pharmaceuticals Business Development Manager Lucia Savage Omada Health Chief Privacy and Regulatory Officer Lisa Schaefer BIO Director of Financial Services and Tax Policy Roman Schenk RECARDIO President Jan Schmidt-Brand Heidelberg Pharma AG CEO Matthew Scholz OncoSenX CEO Josef Schroeter Aktivax Inc. VP Corporate Development Mark Schwartz Theracaine COO Lihi Segal DayTwo Co-Founder and Chief Executive Officer Isaiah Shalwitz Invirsa Co-Founder and VP Jesse Shefferman ArTara Therapeutics, Inc. CEO Wenyuan Shi Forsyth Institute Chief Executive Officer and Chief Scientific Officer Harri Sihto Sartar Therapeutics Chairman of the Board Ruchita Sinha Sanofi Ventures Senior Director of Investments Julie Anne Smith E-Scape Bio Inc. President and CEO Robin Smith Orig3n, Inc. President and CEO Ira Spector SFA Therapeutics CEO Komathi Stem monARC Bionetworks Founder and CEO Jack Stover Interpace Diagnostics Chief Executive Officer Peter Strumph Amygdala Neurosciences, Inc. Co-Founder and CEO Wenn Sun Dr. Reddy's Laboratories Advisor Alex Szidon Merck AVP and Head, West Coast Innovation Hub Mohammad Tabesh GenomeMe CEO Herriot Tabuteau Axsome Therapeutics, Inc. CEO Paul Tanico NeuroDiagnostics (NDX) Principal & CEO Emma Taylor Naked Biome Co-Founder & CEO Helmut Thomas Cyclenium Pharma President and CEO Philip Toleikis Sernova Corp. President, CEO Izabela Tworowska RadioMedix Inc CSO John Valliant Fusion Pharmaceuticals Inc. CEO Thomas Vasicek Gila Therapeutics, Inc. CEO Avanish Vellanki Rain Therapeutics Chief Executive Officer Daniel Vitt Immunic AG CEO Greg Vontz BlackThorn Therapeutics CEO Gregory Wade BTIG Managing Director, Healthcare Investment Banking John Walker Zosano Pharma Corporation CEO Gary Warren ivWatch President and CEO Daniel Weaver Arpeggio Biosciences, Inc. CEO Xiaoxi Wei X-Therma Inc. CEO Genine Winslow Chameleon Biosciences (UCSF) CEO Ryan Witt Immix Biopharma, Inc COO Charles Wolfus MyoKardia Vice President, Digital Health and Business Operations Zhenhua Wu NeuExcell Therapeutics CEO Larry Xi Digenomix Corporation Founder & CEO Matthew Yates Eli Lilly and Company Vice President, Corporate Business Development